Explore the latest in endometrial cancer, including advances in understanding genetic risks for the disease and its diagnosis and management.
This cohort study evaluates the risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment among premenopausal Korean women with breast cancer.
This nonrandomized clinical trial examines the potential positive outcomes and safety of the combination of talazoparib and avelumab in recurrent mismatch repair proficient endometrial cancer.
This cross-sectional study examines trends in cancer mortality among Black individuals in the US from 1999 to 2019 and compares mortality rates in 2019 between the Black population and other racial and ethnic populations.
This randomized clinical trial of women with hormone receptor-positive recurrent or metastatic endometrial cancer examines adverse events and cancer recurrence among patients treated with vistusertib plus anastrozole and compares them with patients treated with anastrozole alone.
This multicenter phase 1/2 nonrandomized controlled trial describes the physician-reported acute genitourinary and gastrointestinal toxic effects and patient-reported quality-of-life changes associated with undergoing stereotactic hypofractionated adjuvant radiation therapy of the pelvis for treatment of uterine cancer.
This cohort study analyzes histologic subtype- and stage-specific uterine cancer mortality rates by race and ethnicity.
This cohort study of a simulated population of Black and White women with postmenopausal bleeding examines the level and accuracy of transvaginal ultrasonography used to identify endometrial thickness indicating the need for biopsy.
This cohort study evaluates the overall survival for patients with uterine cancer with distant organ metastasis treated with chemotherapy alone vs chemotherapy plus total abdominal hysterectomy.
This cohort study examines the diagnostic accuracy, performance characteristics, and morbidity associated with sentinel lymph node biopsy in patients with intermediate- and high-grade endometrial cancer.
This cohort study uses data from the National Cancer Database to investigate the association of neoadjuvant therapy with overall survival in women with metastatic endometrial cancer.
This open-label phase 1 study assesses the antitumor activity, tolerability, and safety of dostarlimab for patients with recurrent or advanced deficient mismatch repair endometrial cancer that has progressed after platinum-containing chemotherapy.
This diagnostic test validates a metabolomics-based classification algorithm as a screening test for endometrial carcinoma.
This qualitative study uses semistructured interviews and an adapted health belief model to describe the beliefs, interpretations, and experiences of symptom onset, symptom disclosure, and diagnosis among black women with endometrial cancer.
This cohort study evaluates the association between the nationwide introduction of minimally invasive robotic surgery in Denmark and severe complications in patients with early-stage endometrial cancer.
This phase 3 randomized clinical trial evaluates the clinical benefit of taxane plus platinum regimens compared with standard doxorubicin plus cisplatin in postoperative adjuvant chemotherapy for endometrial cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.